EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 17 Issue 4
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Editorial Archive

Cell and Gene Therapies are set to Revolutionise Healthcare: Here’s How

The first chemotherapy drugs were discovered by mistake – during World War II – when humans were accidentally exposed to mustard gas. At that time, the only other tr...
19 April 2024 Editorial Archive | Volume 16 Issue 1 cancer | cell
Continue Reading →
Volume 15 Issue 4

Revolutionising Hypertension Management Through Personalised, Data-driven Dose Optimisation

In the late 1990s, Pfizer’s revenue stream was predominantly fuelled from the sales of antihypertensive drugs. The climax, so to speak, of its rigorous anti-hyperten...
24 January 2024 Volume 15 Issue 4 antihypertensive | cardiovascular
Continue Reading →
Regional News

CMS’ Biogen decision could spell problems for Lilly, Roche Alzheimer’s drugs, half of surveyed neurologists say

Neurologists in the U.S. are agreeing with a new draft decision from the Centers for Medicare & Medicaid Services (CMS) that restricts reimbursement of Biogen’s c...
2 February 2022 Regional News Alzheimer | Biogen
Continue Reading →
Regional News

Daiichi Sankyo, with tighter focus on oncology, sells 8 aging US cardiovascular drugs to diversifying Cosette

With the acquisition of the U.S. sales and distribution rights of eight cardiovascular drugs from Daiichi Sankyo, Cosette Pharma of New Jersey is making a move toward...
18 January 2022 Regional News cardiovascular | drugs
Continue Reading →
Europe

AstraZeneca and Lilly’s Alzheimer’s drug fails trial

The battle to develop a drug to treat Alzheimer’s disease has been dealt a blow following disappointing phase 3 trial results. AstraZeneca and Eli Lilly’s lanabecesta...
13 June 2018 Europe 3 | Alzheimer
Continue Reading →
news

Bevacizumab leads clinical trial activity for monoclonal antibodies, says GlobalData

When tracking clinical trial activity across the world, GlobalData, a leading data and analytics company, identified 5,273 industry monoclonal antibodies (mAb) clinic...
29 November 2017 news clinical trial | drugs
Continue Reading →
Catalyst: 12th January 2026
Quotient

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte